Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease. Siegel SAR, Griffith DE, Philley JV, Brown-Elliott BA, et al. Chest 2023;164:846-859.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Siegel SAR, Griffith DE, Philley JV, Brown-Elliott BA, et al. Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease. Chest 2023;164:846-859.
PMID: 37419144